CMC Forum - BioProcess International

Feedback Advertise Reprints About Help Contact

Advanced Search

Upstream Processing Downstream Processing Manufacturing Analytical Facilities

Archive by Issue Archive by Article Type Supplements

CMC Forum

The Roles of Bioactivity Assays in Lot Release and Stability Testing

BioProcess International, Vol. 8, No. 6, June 2010, pp. 33–42

Practical Applications of Quality Risk Management

BioProcess International, Vol. 8, No. 3, March 2010, pp. 20–32

Raw Material Control Strategies for Bioprocesses

BioProcess International, Vol. 7, No. 8, September 2009, pp. 18–33

Defining Your Product Profile and Maintaining Control Over It, Part 2

BioProcess International, Vol. 3, No. 8, September 2005, pp. 52-57

What Is Test Method Qualification?

BioProcess International, Vol. 2, No. 8, September 2004, pp. 32–46

Quality by Design: The Next Phase

BioProcess International, Vol. 7, No. 1, January 2009, pp. 34–42

Defining Your Product Profile and Maintaining Control Over It, Part 1

BioProcess International, Vol. 3, No. 6, June 2005, pp. 32–40

Lot Release and Characterization Testing of Live-Virus-Based Vaccines and Gene Therapy Products, Part 2

BioProcess International, Vol. 4, No. 5, May 2006, pp. 56-65

Lot Release and Characterization Testing of Live-Virus-Based Vaccines and Gene Therapy Products, Part 1

BioProcess International, Vol. 4, No. 4, April 2006, pp. 46-54

Defining Your Product Profile and Maintaining Control Over It, Part 4

BioProcess International, Vol. 3, No. 10, November 2005, pp. 50-54

Defining Your Product Profile and Maintaining Control Over It, Part 3

BioProcess International, Vol. 3, No. 9, October 2005, pp. 50-56

Demonstrating Comparability for Well-Characterized Biotechnology Products

BioProcess International, Vol. 6, No. 2, February 2008, pp. 32–43

The Best of GE Healthcare: Tools for vaccine processes

In vaccine development and manufacturing, GE Healthcare provides a suite of scalable solutions from cell culture through purification to analysis, which offer flexibility and economy, improve purity and secure quality.

Microcarriers and disposable bioreactors for MDCK and Vero cell culture
Secure cell propagation with adherent cells at reduced cost and with increased flexibility

DNA removal from influenza virus culture
HTPD and DoE for development and optimization of a chromatography step for the removal of host cell derived genomic DNA

Editors' Blog

On the (BPI) Road (Part 2)

More Travel Tips from the Editor in Chief

Practical Considerations for DoE Implementation in Quality By Design

BioProcess International Conference & Exhibition

I'm Losing Cell Viability and Function at Different Points in My Process, and I Don't Know Why!

Measuring Manufacturing Cost and Its Impact on Organizations

Contractor Responsibilities in Outsourced Pharmaceutical Quality Control Testing

The Roles of Bioactivity Assays in Lot Release and Stability Testing

Current Issue